Short answers, pulled from the story.
John D. Rockefeller III founded the Population Council in 1952, with important funding from the Rockefeller Brothers Fund. He convened scientists in Williamsburg, Virginia, under the auspices of the National Academy of Sciences before establishing the organization as an independent nonprofit.
The Population Council developed the Copper T intrauterine device, Norplant, Jadelle (Norplant II), Mirena, and Annovera. The Copper T IUD has been distributed to more than 50 million people in over 70 countries, and Annovera was approved by the US FDA in 2018.
The Population Council works in more than 60 countries and maintains 18 offices across Africa, Asia, and Latin America. It employs nearly 400 people from 33 countries, with roughly 55 percent based outside the United States.
The Population Council operates with an annual budget of around $74 million. The organization is headquartered in New York City and is governed by an international board of trustees.
The Population Council publishes Population and Development Review, which covers the interrelationships between population and socioeconomic development, and Studies in Family Planning, which focuses on public health, social science, and biomedical research involving sexual and reproductive health, fertility, and family planning.
One-third of the Population Council's research relates to HIV and AIDS. The organization was among the first to document HIV statistics in Africa and conducted the first study in India to assess HIV risks for injecting drug users.